Janus Henderson Biotech Innovation Master Fund Ltd

10% OwnerARCA biopharma, Inc. (ABIO) · full profile →Form 4 · filed Jul 12, 2024
Net Buying
Open-Market Buys
$1.4M
Open-Market Sells
$0
Net Open-Market Flow
$1.4M
Transactions
9
9 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 11, 2024Buy(P)95K$3.45$326K1.9M
Jul 10, 2024Buy(P)22K$3.46$76K1.8M
Jul 10, 2024Buy(P)34K$3.46$116K1.8M
Jul 9, 2024Buy(P)17K$3.43$58K1.7M
Jul 8, 2024Buy(P)18K$3.54$62K1.7M
Jul 8, 2024Buy(P)30K$3.41$102K1.7M
Jul 5, 2024Buy(P)5K$3.41$17K1.7M
Jul 5, 2024Buy(P)23K$3.43$80K1.7M
Jul 3, 2024Buy(P)166K$3.55$589K1.6M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001437749-24-022708) within minutes of acceptance. Every field above traces to the original document. Verify it directly: